Clover Health Investments Corp Cla (CLOV)
EBITDA Growth
59.97%
TTM · Period ending:
CLOV EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported59.97%period ending
Latest reported59.97%period ending
CLOV TTM EBITDA YoY % (66.06% → 59.97%)
Year-over-year change
High-resolution chart · PNG
CLOV ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 59.9713% | |
| -135.6311% | |
| -87.8104% | |
| 39.8804% | |
| 64.9771% | |
| 84.6641% | |
| 78.5685% | |
| 58.2117% | |
| 55.6526% | |
| 55.0919% | |
| 38.1446% | |
| 49.0213% | |
| 33.4166% | |
| 44.2716% | |
| 40.8643% | |
| 11.2032% | |
| 8.1321% | |
| -525.2064% | |
| -623.4945% | |
| -1,696.9734% | |
| -679.0327% | |
| 39.1395% | |
| 66.0576% |